As of 2025-07-04, the EV/EBITDA ratio of INVO Bioscience Inc (INVO) is -1.13. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INVO's latest enterprise value is 5.81 mil USD. INVO's TTM EBITDA according to its financial statements is -5.14 mil USD. Dividing these 2 quantities gives us the above INVO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.3x - 19.3x | 18.0x |
| Forward P/E multiples | 20.0x - 23.5x | 22.4x |
| Fair Price | (21.20) - (20.43) | (21.39) |
| Upside | -2644.8% - -2552.4% | -2667.9% |
| Date | EV/EBITDA |